Founder of 5 different companies, including: Medivation LLC (California), Nuvation Bio, Inc. and Medivation, Inc. David T. Hung is an entrepreneur and businessperson who has been at the helm of 10 different companies and occupies the position of President, Chief Executive Officer & Director at Repharmation, Inc. (which he founded) and President, Chief Executive Officer & Director at Nuvation Bio, Inc. (which he founded in 2018), President, Chief Executive Officer & Director at Nuvation Bio Operating Co., Inc. (which he founded in 2018) (a subsidiary of Nuvation Bio, Inc.). Dr. Hung is also on the board of NovoCure Ltd., Establishment Labs SA and Auransa, Inc.

In the past Dr. Hung was Chief Executive Officer & Director at Sio Gene Therapies, Inc. and Chief Executive Officer & Director at Axovant Sciences, Inc. (a subsidiary of Sio Gene Therapies, Inc.), President & Chief Executive Officer at Orion Acquisition Corp. II, President, Chief Executive Officer & Director at Pro-Duct Health, Inc., President, Chief Executive Officer & Director at Medivation, Inc. (he founded the company in 2003), President, Chief Executive Officer & Director at Medivation LLC (California) (he founded the company in 1995), President, Chief Executive Officer & Director at Medivation Neurology LLC, VP-Lead Discovery, Development & New Projects at Chiron Corp. and Consultant at Cytyc Health Corp.

David T. Hung received an undergraduate degree from Harvard College and a doctorate from UCSF School of Medicine.